Ablation Strategies for Repeat Procedures in Atrial Fibrillation Recurrences Despite Durable Pulmonary Vein Isolation: The Prospective Randomized ASTRO AF Multicenter Trial

医学 心房颤动 肺静脉 烧蚀 心脏病学 四分位间距 内科学 房性心动过速 导管消融 随机对照试验 心耳 临床终点 外科 射频消融术 前瞻性队列研究 窦性心律
作者
Boris Schmidt,Stefano Bordignon,Andreas Metzner,Philipp Sommer,Daniel Steven,Tillman Dahme,Matthias Busch,Roland Richard Tilz,David Schaack,Andreas Rillig,Christian Sohns,Arian Sultan,Karolina Weinmann,Astrid Hummel,Julia Vogler,Thomas Fink,Jakob Lueker,Alexander Pott,Christian‐Hendrik Heeger,K. R. Julian Chun
出处
期刊:Circulation [Lippincott Williams & Wilkins]
卷期号:150 (25): 2007-2018 被引量:7
标识
DOI:10.1161/circulationaha.124.069993
摘要

BACKGROUND: Ablation strategies for patients with symptomatic atrial fibrillation and isolated pulmonary veins vary and their effects on arrhythmia recurrence remain unclear. A prospective randomized German multicenter trial sought to compare 2 ablation strategies in this patient cohort. METHODS: Patients with atrial fibrillation despite durable pulmonary vein isolation were randomly assigned at 7 centers to undergo low-voltage area ablation using 3-dimensional mapping and irrigated radiofrequency current ablation (group A) or empirical left atrial appendage isolation (LAAI) using the cryoballoon followed by staged interventional left atrial appendage closure (group B). The primary end point was freedom from atrial tachyarrhythmias between 91 and 365 days after index ablation. The study was powered for superiority of LAAI compared with low-voltage area. RESULTS: Patients (40% women; mean age, 68.8±8 years) with paroxysmal (32%) or persistent atrial fibrillation (68%) were randomized to undergo low-voltage area ablation (n=79) or cryoballoon-guided LAAI (n=82). After a planned interim analysis, enrollment was halted for futility on January 10, 2023. In the LAAI group, 77 of 82 left atrial appendages were successfully isolated with subsequent left atrial appendage closure in 57 patients. Procedure-related complications occurred in 4 (5%) and 11 (13.5%) patients in group A and B, respectively ( P =0.10). The median follow-up was 367 days (interquartile range, 359–378). The Kaplan-Meier point estimate for freedom from atrial tachyarrhythmias was 51.7% (CI, 40.9%–65.4%) for group A and 55.5% (CI, 44.4%–69.2%; P =0.8069) for group B. CONCLUSIONS: The current study did not detect superiority of cryoballoon-guided LAAI over low-voltage area ablation in patients with atrial fibrillation despite durable PVI. REGISTRATION: URL: https://www.clinicaltrials.gov ; Unique identifier: NCT04056390.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
刚刚
2秒前
xiaoder发布了新的文献求助30
2秒前
2秒前
俏皮的孤丹完成签到 ,获得积分10
2秒前
3秒前
纯真的雨发布了新的文献求助10
4秒前
今后应助张张采纳,获得10
4秒前
碧蓝雨真完成签到,获得积分10
5秒前
5秒前
wonder123发布了新的文献求助10
5秒前
6秒前
7秒前
天天发布了新的文献求助10
8秒前
8秒前
李洋发布了新的文献求助10
8秒前
nnnaaaa发布了新的文献求助10
9秒前
Lina完成签到,获得积分10
9秒前
Guo99完成签到,获得积分10
9秒前
9秒前
麦当劳开我家楼下完成签到,获得积分10
10秒前
惠小之完成签到,获得积分10
10秒前
花花发布了新的文献求助10
10秒前
11秒前
Y.J完成签到,获得积分10
14秒前
求求科研发布了新的文献求助10
15秒前
15秒前
molihuakai应助thhsun采纳,获得10
15秒前
15秒前
NexusExplorer应助天天采纳,获得10
15秒前
乐乐应助大大撒采纳,获得10
16秒前
约以文完成签到,获得积分10
16秒前
kbcbwb2002完成签到,获得积分0
17秒前
18秒前
公子渔发布了新的文献求助10
18秒前
毛毛完成签到,获得积分10
21秒前
北极光发布了新的文献求助10
22秒前
顾矜应助花花采纳,获得10
23秒前
大力帽子发布了新的文献求助10
23秒前
隐形曼青应助xiaoder采纳,获得10
24秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
Prompt Engineering for Clinicians: Harnessing AI in Everyday Medical Practice 600
University Physics for the Life Sciences 500
REAL-WORLD EFFICACY AND GENOMIC LANDSCAPE OF POLATUZUMA VEDOTIN-BASED FIRST-LINE THERAPY IN DIFFUSE LARGE B-CELL LYMPHOMA: A FOCUS ON TP53 MUTATIONS AND TREATMENT RESPONSE 500
Handbook of Luminescence Dating 500
Safety Pharmacology 500
《KNN基无铅压电陶瓷电学性能优化与物理机理研究》 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 工程类 有机化学 计算机科学 化学工程 生物化学 物理 内科学 复合材料 催化作用 光电子学 物理化学 电极 细胞生物学 基因 遗传学
热门帖子
关注 科研通微信公众号,转发送积分 6955240
求助须知:如何正确求助?哪些是违规求助? 8638851
关于积分的说明 18319535
捐赠科研通 6400180
什么是DOI,文献DOI怎么找? 3083540
关于科研通互助平台的介绍 2130001
邀请新用户注册赠送积分活动 2060361